AKAM vs ETON · P/E 27, rev $2.17B vs rev $61.9M
Akamai Technologies Inc (AKAM) versus Eton Pharmaceuticals Inc (ETON) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Eton Pharmaceuticals Inc (ETON) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported ETON revenue for 2026-06-30 was $61.9M. Net income was $13.1M. ETON currently screens at market cap $797.9M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. ETON currently screens at market cap $797.9M.
Not investment advice. Open the AKAM and ETON stock pages for the full models.
Not investment advice.